ORLANDO, Fla., Feb. 28, 2008 (PRIME NEWSWIRE) -- RedChip Independent, a division of RedChip Companies Inc., today announced it has issued a second quarter 2008 research update for Synthetech, Inc. (OTCBB:NZYM).
Suman Preet Kaur, MBS, RedChip Research Analyst, wrote in the report:
"Synthetech has been aggressively involved with the development of new drugs. The overall biopharmaceutical industry has witnessed a significant uptrend since 2006 as a large number of drugs lose patent protection and become generic. This would benefit a smaller niche company such as Synthetech by increasing its customer base and revenue. Due to such improvement in the business environment, NZYM has increased its sales presence in the NAFTA and European markets, expanded its existing relationships and increased its visibility in the marketplace. NZYM also plans to enter into lucrative areas such as active pharmaceutical ingredients (API) in order to maximize gains from the industry uptrend. We believe the market environment has improved for NZYM's products, and we are reinitiating a 'Buy' recommendation on Synthetech."
About RedChip Independent:
RedChip Companies Inc. is a well-established source of independent research and information on the small-cap market. Dedicated to "Discovering Tomorrow's Blue Chips Today," its analysts seek out up-and-coming and undiscovered small-cap companies before they show up on Wall Street's radar screen. To view the full version of this report, to include the investment conclusion and target price, subscribe to RedChip's Research Community online by visiting http://www.redchip.com/visibility/redchipResearchNEW.asp or call 1-800-REDCHIP.
Disclosure:
The views expressed in this report, (which includes the actual rating assigned to the company as well as the analytical substance and tone of the report), accurately reflect the personal views of the analyst(s) covering the subject securities. No part of the analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views contained in this research report. The analyst(s) contributing to this report do not hold any shares of the subject securities. Additional information on the securities mentioned in this report is available upon request. This report is based on data obtained from sources we believe to be reliable but is not guaranteed as to accuracy and does not purport to be complete. As such, neither the information nor any opinion expressed constitutes an offer, or an invitation to make or garner an offer, to buy or sell any securities or any options, futures or other derivatives related to such securities ("related investments"). This publication was furnished on the condition that it will not form a primary basis for any investment decision. Each investor must make their own determination of the appropriateness of an investment in any securities referred to herein based on the legal, tax, and accounting considerations applicable to such investor and their own investment strategy. Any opinions expressed herein are subject to change. The subject security is not a client of RedChip Companies, Inc., or any of its affiliates.